Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2020 · 10-Q
Revenue$8.27M$8.27M−44.5% vs Q1 2019 Net Income-$5.15M-$5.15MN/M vs Q1 2019 EPS Diluted-$0.05-$0.05N/M vs Q1 2019 Gross Profit$4,008,000−62.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow-$1,691,000N/M Free Cash Flowderived-$2,171,000N/M Margins · derivedGross margin48.5%−22.3 pt vs Q1 2019
Operating margin-64.3%−1.4 pt vs Q1 2019
Net margin-62.3%+0.6 pt vs Q1 2019
ended Mar 31, 2020 · filed May 8, 2020 · 38 d after period end